29 03, 2017

Argentina’s Patent Office signs bilateral agreement with the US harming public health and national laws

2017-03-29T20:16:15-03:00miércoles, 29 marzo, 2017|Access to Medicines, Argentina, Health Safeguards, Intellectual Property, Public Health|

The Argentinian National Institute of Industrial Property (INPI, by its acronym in Spanish) signed a bilateral agreement with the US Patent Office on February 13th that includes reciprocal acceptance of patenting results of both offices. The news are grave and serious as the "Patent Prosecution Highway Between USPTO and INPI-Argentina" effectively repeals the Argentine Patent

17 12, 2015

FGEP continues defense of public health in Argentina against the abuse of the patent system by multinational pharmaceutical companies

2015-12-17T03:50:58-03:00jueves, 17 diciembre, 2015|Access to Medicines, Argentina, Direct Action, Health Safeguards, HIV, Intellectual Property, Kaletra, Patent opposition, Sofosbuvir|

BUENOS AIRES, December 15th 2015 - Fundación Grupo Efecto Positivo (FGEP), an organization whose work is focused on guaranteeing access to essential medicines for HIV and Hepatitis C in Argentina and Latin America, announced in a press conference on November 30th two new key actions to defend public health policies. Dr. Daniel Gollán, Argentina’s Minister

4 11, 2015

Argentina could save U$11M per year buying generic version of Truvada®

2015-11-04T20:01:06-03:00miércoles, 4 noviembre, 2015|Access to Medicines, Advocacy, Health Safeguards, Intellectual Property, Patent opposition|

The Argentine Community of People Living with HIV requested the rejection of a patent for an essential HIV/AIDS medicine. If the Argentine Patent Office does grant the this request, Argentina could produce generic versions at a lower cost representing a potential saving of over US$11 million. Argentina April 13th, 2015.- The Grupo Efecto Positivo Foundation (FGEP) in collaboration with the Argentine

11 09, 2015

UNAIDS “4th 90”: Affordability of Medicines

2015-11-04T16:38:17-03:00viernes, 11 septiembre, 2015|909090 Strategy, Access to Medicines, Argentina, Medicines, Ministry of Health, Public Health, UNAIDS|

UNAIDS has seen Argentina´s proposal to add a 4th “90” to its 909090 Strategy as a model to be implemented worldwide Buenos aires, September 2015 – UNAIDS´s Executive Director, Michel Sidibé, visit Argentina and Chile in his first time visit to Latin American region as part of a global tour to promote 90-90-90 strategy which

29 07, 2015

World Viral Hepatitis Day: Challenges and Progress in Argentina for access to treatments that cure

2015-11-04T14:06:31-03:00miércoles, 29 julio, 2015|Access to Medicines, Advocacy, Hepatitis C, Intellectual Property, Ministry of Health, Public Health|

BUENOS AIRES - On World Viral Hepatitis Day, Fundación Grupo Efecto Positivo (FGEP) held a meeting with officials from Argentina’s Ministry of Health, articulating and coordinating actions and strategies that promote access to sofosbuvir, an essential drug for Hepatitis C treatment. The need for joint action originates from the great challenge both Argentina and Latin

22 07, 2015

FGEP and the Ministry of Industry agree on agenda to jointly work for Access to Medicines

2015-11-04T13:56:27-03:00miércoles, 22 julio, 2015|Access to Medicines, Health Safeguards, Intellectual Property, Medicines, Public Health|

BUENOS AIRES  – On Tuesday July 21st members of Fundación GEP met with the head of the Ministry of Industry, Lic. Débora Giorgi, and the President of the National Institute of Industrial Property (INPI) Cdor. Mario Aramburu, to analize the topics of the joint agenda on access to medicines and intellectual property. Among these were reviewed the presentations

2 07, 2015

International Forum: Access to HIV and Hepatitis C Medicines

2015-10-30T18:02:25-03:00jueves, 2 julio, 2015|Access to Medicines, Capacity Building, Hepatitis C, HIV, Intellectual Property, RedLAM|

Citizens, organizations and experts analyzed the current challenges to hep C and HIV medicine’s access at the International Forum organized by RedLAM Citizens, NGO’s, experts and national authorities of Latin-American Countries exchanged ideas and strategic courses of action to boost Access to medicines at the “International Forum about Access to Medicines, Intellectual Property and Local

20 05, 2015

Patent opposition for Sofosbuvir requested in Argentina

2015-11-04T16:41:16-03:00miércoles, 20 mayo, 2015|Access to Medicines, Advocacy, Health Safeguards, Hepatitis C, Public Health|

Organizations of people with hepatitis C have filed an opposition for a patent that would prevent 800,000 people from having access to treatment in Argentina Fundación Grupo Efecto Positivo (FGEP) leads the opposition to pharmaceutical patents movement as a key strategy to ensure access to medicines The growing global movement to guarantee access to medicines

Ir a Arriba